2023
Abstract P6-04-19: Engaging pathologists in a social peer-to-peer learning collaborative to discuss the emergence of HER2-low breast cancer
Cancer Research
doi.org/10.1158/1538-7445.SABCS22-P6-04-19
Cancer Research
doi.org/10.1158/1538-7445.SABCS22-P6-04-19
2022
|
Reducing preventable ED visits in patients with advanced NSCLC: Collective insights from three cancer centers
Journal of Clinical Oncology doi.org/10.1200/JCO.2022.40.28_suppl.337 Leveraging continuing education and implementation science approaches to improve the care of patients with myeloproliferative neoplasms Journal of Clinical Oncology doi.org/10.1200/JCO.2022.40.28_suppl.334 Empowering pathologists to lead immuno-oncology (IO) biomarker testing in the community Journal of Clinical Oncology doi.org/10.1200/JCO.2022.40.28_suppl.348 A mixed-methods study to identify key priorities around improving team-based care coordination for patients receiving combination IV and oral systemic anti-cancer therapy Journal of Clinical Oncology doi.org/10.1200/JCO.2022.40.28_suppl.052 Association of Community Cancer Centers key quality care recommendations for stage IB to IIIA non–small cell lung cancer Journal of Clinical Oncology doi.org/10.1200/JCO.2022.40.28_suppl.030 Building a multidisciplinary consortium in Iowa to advance genetic counseling and testing in patients with cancer Journal of Clinical Oncology doi.org/10.1200/JCO.2022.40.16_suppl.10609 A multiphase continuing education and quality improvement initiative to tailor treatment plans for patients with follicular lymphoma Journal of Clinical Oncology doi.org/10.1200/JCO.2022.40.16_suppl.e18651 |
Enhancing Coordination Around Cancer Biomarker and Hereditary Genetic Testing Among Members of the Multidisciplinary Care Team
American Journal of Clinical Pathology doi.org/10.1093/ajcp/aqac126.310 Leadership Insights From a Pathology Peer-to-Peer Learning Collaborative in Immuno-oncology American Journal of Clinical Pathology doi.org/10.1093/ajcp/aqac126.309 Engaging Pathologists in a Peer-to-Peer Learning Collaborative on HER2-Low Breast Cancer American Journal of Clinical Pathology doi.org/10.1093/ajcp/aqac126.082 |
2021
Learnings from a multiphase, mixed-methods lung cancer quality initiative in U.S. community cancer centers
Journal of Clinical Oncology
doi.org/10.1200/JCO.2020.39.28_suppl.254
A Multi-Phase Quality Initiative to Improve Processes of Care for Non-small Cell Lung Cancer (NSCLC) in US Community Cancer Centers
Journal of Thoracic Oncology
doi.org/10.1016/j.jtho.2021.08.555
Proactively Improving the Management of Immune-Related Adverse Events (irAEs) in a Community Cancer Program
Journal of Thoracic Oncology
doi.org/10.1016/j.jtho.2019.08.2367
Journal of Clinical Oncology
doi.org/10.1200/JCO.2020.39.28_suppl.254
A Multi-Phase Quality Initiative to Improve Processes of Care for Non-small Cell Lung Cancer (NSCLC) in US Community Cancer Centers
Journal of Thoracic Oncology
doi.org/10.1016/j.jtho.2021.08.555
Proactively Improving the Management of Immune-Related Adverse Events (irAEs) in a Community Cancer Program
Journal of Thoracic Oncology
doi.org/10.1016/j.jtho.2019.08.2367
2018
Improving Process of Care Measures For Patients With IBD: Key Findings From A QI Pilot
Inflammatory Bowel Diseases
doi.org/10.1093/ibd/izy038.022
Inflammatory Bowel Diseases
doi.org/10.1093/ibd/izy038.022